Modulation of Infection with Histoplasma capsulatum by Inhibition of Tumor Necrosis Factor–α Activity
Open Access
- 1 August 2005
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (Supplement) , S204-S207
Abstract
Tumor necrosis factor (TNF)–α is required for host defenses against a number of pathogenic microbes, including Histoplasma capsulatum. In mice, TNF-αKeywords
This publication has 15 references indexed in Scilit:
- Protective and Memory Immunity to Histoplasma capsulatum in the Absence of IL-10The Journal of Immunology, 2003
- Histoplasmosis after Treatment with Anti–Tumor Necrosis Factor-α TherapyAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanerceptArthritis & Rheumatism, 2002
- Regulation of Infection with Histoplasma capsulatum by TNFR1 and -2The Journal of Immunology, 2000
- Neutralization of Endogenous Granulocyte-Macrophage Colony-Stimulating Factor Subverts the Protective Immune Response to Histoplasma capsulatumThe Journal of Immunology, 1999
- Complex Requirements for Nascent and Memory Immunity in Pulmonary HistoplasmosisThe Journal of Immunology, 1999
- Blockade of Endogenous TNF-α Exacerbates Primary and Secondary Pulmonary Histoplasmosis by Differential MechanismsThe Journal of Immunology, 1998
- Modulation of Immune Responses in Murine Pulmonary HistoplasmosisThe Journal of Infectious Diseases, 1997
- IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γThe Journal of Immunology, 1995
- Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in miceInfection and Immunity, 1992